Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry
- PMID:8131270
Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry
Abstract
We tested 231 urine samples by six immunoassay methods--EMIT d.a.u., EMIT II, Roche Abuscreen Online, Abbott TDx, Diagnostic Products Corp. (DPC) double-antibody radioimmunoassay (RIA), and Biosite Triage--and by negative chemical ionization gas chromatography/mass spectrometry to determine how the immunoassays performed on samples selected for suspected benzodiazepine use (n = 100) and in random urine drug screening (n = 131). In general, all of the assays were successful in detecting oxazepam and related metabolites, even at concentrations below the stated cutoffs. However, the negative predictive value of benzodiazepine immunoassays for samples selected for suspected benzodiazepine use ranged from 86% to 96%. A primary difference between the test kits was the ability of DPC RIA and Triage to detect lorazepam when other assays did not. Contrary to previous reports, pretreatment of specimens with glucuronidase was not necessary to detect oxazepam-related metabolites with these immunoassays.
Similar articles
- Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required.Meatherall R.Meatherall R.J Anal Toxicol. 1994 Nov-Dec;18(7):385-90. doi: 10.1093/jat/18.7.385.J Anal Toxicol. 1994.PMID:7861751
- Limitations of EMIT benzodiazepine immunoassay for monitoring compliance of patients with benzodiazepine therapy even after hydrolyzing glucuronide metabolites in urine to increase cross-reactivity: comparison of immunoassay results with LC-MS/MS values.Dixon RB, Floyd D, Dasgupta A.Dixon RB, et al.Ther Drug Monit. 2015 Feb;37(1):137-9. doi: 10.1097/FTD.0000000000000117.Ther Drug Monit. 2015.PMID:25004136
- Comparison of different immunoassays and GC-MS screening of benzodiazepines in urine.Augsburger M, Rivier L, Mangin P.Augsburger M, et al.J Pharm Biomed Anal. 1998 Dec;18(4-5):681-7. doi: 10.1016/s0731-7085(98)00266-0.J Pharm Biomed Anal. 1998.PMID:9919969
- Improved screening for benzodiazepine metabolites in urine using the Triage Panel for Drugs of Abuse.Koch TR, Raglin RL, Kirk S, Bruni JF.Koch TR, et al.J Anal Toxicol. 1994 May-Jun;18(3):168-72. doi: 10.1093/jat/18.3.168.J Anal Toxicol. 1994.PMID:7914948
- Enzyme immunoassays in clinical chemistry: present status and trends.Oellerich M.Oellerich M.J Clin Chem Clin Biochem. 1980 Apr;18(4):197-208. doi: 10.1515/cclm.1980.18.4.197.J Clin Chem Clin Biochem. 1980.PMID:6770030Review.
Cited by
- Recent findings and advancements in the detection of designer benzodiazepines: a brief review.Wu D, Fu L.Wu D, et al.Arh Hig Rada Toksikol. 2023 Dec 29;74(4):224-231. doi: 10.2478/aiht-2023-74-3771. eCollection 2022.Arh Hig Rada Toksikol. 2023.PMID:38146763Free PMC article.Review.
- Buyer Beware: Pitfalls in Toxicology Laboratory Testing.Algren DA, Christian MR.Algren DA, et al.Mo Med. 2015 May-Jun;112(3):206-10.Mo Med. 2015.PMID:26168592Free PMC article.
- A Review of Drug Abuse, Misuse, and Related Laboratory Challenges.Ranjkeshzadeh H, Sepahi S, Zare-Zardini H, Taghavizadeh Yazdi ME, Ghorani-Azam A, Jafari A.Ranjkeshzadeh H, et al.Curr Drug Saf. 2024;19(4):417-430. doi: 10.2174/0115748863266621231023112044.Curr Drug Saf. 2024.PMID:37957844Review.
- False-Positive Urine Screening for Benzodiazepines: An Association with Sertraline?: A Two-year Retrospective Chart Analysis.Nasky KM, Cowan GL, Knittel DR.Nasky KM, et al.Psychiatry (Edgmont). 2009 Jul;6(7):36-9.Psychiatry (Edgmont). 2009.PMID:19724768Free PMC article.
- Comparison of two highly sensitive benzodiazepine immunoassay lab developed tests for urine drug testing in clinical specimens.Lund K, Menlyadiev M, Lee K, Kelner MJ, Fitzgerald RL, Suhandynata RT.Lund K, et al.J Mass Spectrom Adv Clin Lab. 2023 Mar 1;28:91-98. doi: 10.1016/j.jmsacl.2023.02.010. eCollection 2023 Apr.J Mass Spectrom Adv Clin Lab. 2023.PMID:36937812Free PMC article.